1026468-03-0Relevant academic research and scientific papers
Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group
Gowravaram,Tomczuk,Johnson,Delecki,Cook,Ghose,Mathiowetz,Spurlino,Rubin,Smith,Pulvino,Wahl
, p. 2570 - 2581 (2007/10/02)
In this study, structure-based drug design of matrix metalloproteinase inhibitors [human fibroblast collagenase (HFC), human fibroblast stromelysin (HFS), and human neutrophil collagenase (HNC)] was utilized in the development of potent hydroxamates which
